223 related articles for article (PubMed ID: 28277300)
1. Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma.
Jiao C; Jiao X; Zhu A; Ge J; Xu X
J Pediatr Surg; 2017 Apr; 52(4):618-624. PubMed ID: 28277300
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.
Liu W; Chen S; Liu B
Pediatr Surg Int; 2016 Nov; 32(11):1059-1065. PubMed ID: 27601233
[TBL] [Abstract][Full Text] [Related]
3. Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: A Chinese population-based study.
Jiao C; Zhu A; Jiao X; Ge J; Xu X
J Pediatr Surg; 2016 Aug; 51(8):1355-61. PubMed ID: 27046304
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
Wu B; Zhen K; Guo L; Sun C
Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
[No Abstract] [Full Text] [Related]
6. Glypican 3 as a Serum Marker for Hepatoblastoma.
Zhou S; O'Gorman MR; Yang F; Andresen K; Wang L
Sci Rep; 2017 Apr; 7():45932. PubMed ID: 28378832
[TBL] [Abstract][Full Text] [Related]
7. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
[TBL] [Abstract][Full Text] [Related]
8. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
9. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
[TBL] [Abstract][Full Text] [Related]
10. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
[TBL] [Abstract][Full Text] [Related]
11. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
[TBL] [Abstract][Full Text] [Related]
13. Circulating Exosomal miR-27a and miR-130a Act as Novel Diagnostic and Prognostic Biomarkers of Colorectal Cancer.
Liu X; Pan B; Sun L; Chen X; Zeng K; Hu X; Xu T; Xu M; Wang S
Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):746-754. PubMed ID: 29739748
[No Abstract] [Full Text] [Related]
14. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
[TBL] [Abstract][Full Text] [Related]
15. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma.
Wang J; Zhou Y; Lu J; Sun Y; Xiao H; Liu M; Tian L
Med Oncol; 2014 Sep; 31(9):148. PubMed ID: 25099764
[TBL] [Abstract][Full Text] [Related]
16. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
Sohn W; Kim J; Kang SH; Yang SR; Cho JY; Cho HC; Shim SG; Paik YH
Exp Mol Med; 2015 Sep; 47(9):e184. PubMed ID: 26380927
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
Takahasi K; Iinuma H; Wada K; Minezaki S; Kawamura S; Kainuma M; Ikeda Y; Shibuya M; Miura F; Sano K
J Hepatobiliary Pancreat Sci; 2018 Feb; 25(2):155-161. PubMed ID: 29130611
[TBL] [Abstract][Full Text] [Related]
19. Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease.
Eissa S; Matboli M; Aboushahba R; Bekhet MM; Soliman Y
J Diabetes Complications; 2016; 30(8):1585-1592. PubMed ID: 27475263
[TBL] [Abstract][Full Text] [Related]
20. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
